Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Urinary Tract Infections 1Staphylococcal Infections 1Spasm 1Sleep Initiation and Maintenance Disorders 1Sepsis 1Seizures 1Sedentary Behavior 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1Retinitis 1Renal Insufficiency, Chronic 1Pulmonary Arterial Hypertension 1Pneumonia 1Pain 1Neutropenia 1Multiple Endocrine Neoplasia Type 1 1Migraine Disorders 1Menorrhagia 1Meningitis, Bacterial 1Meningitis 1Intraabdominal Infections 1Insulin Resistance 1Influenza, Human 1Inflammation 1Infections 1Hypokalemia 1Hypertension 1Hyperlipidemias 1Hyperglycemia 1Hyperaldosteronism 1

Interventions

ziprasidone 1Resistance Training 1Olanzapine 1Nutrition Assessment 1Monitoring, Physiologic 1Masks 1Hospitals, High-Volume 1Exercise Test 1Exercise 1Creatine 1Cognitive Behavioral Therapy 1Blood Glucose Self-Monitoring 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Sedentary Behavior × ziprasidone × Clear all
NCT00910988 2018-07-18

Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone

Washington University School of Medicine

Phase NA Completed
46 enrolled 38 charts
Endocrine

Hyperglycemia, Hyperlipidemias, Insulin Resistance, Multiple Endocrine Neoplasia Type 1, Sedentary Behavior

Data powered by HemOnc (CC BY 4.0) Colophon âš¡